Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases
- PMID: 19536360
- DOI: 10.1358/mf.2009.31.3.1364241
Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases
Abstract
Citicoline is an essential precursor in the synthesis of phosphatidylcholine, a key cell membrane phospholipid, and is known to have neuroprotective effects in acute ischemic stroke. The aim of this study was to determine the efficacy and safety of oral citicoline in Korean patients with acute ischemic stroke. A drug surveillance study was carried out in 4,191 patients with a diagnosis of acute ischemic stroke. Oral citicoline (500-4000 mg/day) was administered within less than 24 h after acute ischemic stroke in 3,736 patients (early group) and later than 24 h after acute ischemic stroke in 455 patients (late group) for at least 6 weeks. For efficacy assessment, primary outcomes were patients' scores obtained with a short form of the National Institutes of Health Stroke Scale (s-NIHSS), a short form of the Barthel Index of activities of daily living (s-BI) and a modified Rankin Scale (mRS) at enrollment, after 6 weeks and at the end of therapy for those patients with extended treatment. All adverse reactions were monitored during the study period for safety assessment. All measured outcomes, including s-NIHSS, s-BI and mRS, were improved after 6 weeks of therapy (P < 0.05). Further improvement was observed in 125 patients who continued citicoline therapy for more than 12 weeks when compared with those who ended therapy at week 6. Improvements were more significant in the higher dose group (> or = 2000 mg/day) (P < 0.001). s-BI scores showed no differences between the early and late groups at the end of therapy. Citicoline safety was excellent; 37 side effects were observed in 31 patients (0.73%). The most frequent findings were nervous system-related symptoms (8 of 37, 21.62%), followed by gastrointestinal symptoms (5 of 37, 13.5%). Oral citicoline improved neurological, functional and global outcomes in patients with acute ischemic stroke without significant safety concerns.
Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.
Similar articles
-
Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.Ann Neurol. 2000 Nov;48(5):713-22. Ann Neurol. 2000. PMID: 11079534 Clinical Trial.
-
[Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment].Rev Neurol. 2001 May 1-15;32(9):818-21. Rev Neurol. 2001. PMID: 11424030 Spanish.
-
Citicoline for acute ischemic stroke in Mexican hospitals: a retrospective postmarketing analysis.Methods Find Exp Clin Pharmacol. 2010 Jun;32(5):325-30. doi: 10.1358/mf.2010.32.5.1465004. Methods Find Exp Clin Pharmacol. 2010. PMID: 20664823
-
Citicoline: pharmacological and clinical review, 2006 update.Methods Find Exp Clin Pharmacol. 2006 Sep;28 Suppl B:1-56. Methods Find Exp Clin Pharmacol. 2006. PMID: 17171187 Review.
-
The effects of citicoline on acute ischemic stroke: a review.J Stroke Cerebrovasc Dis. 2014 Aug;23(7):1764-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.01.020. Epub 2014 Apr 13. J Stroke Cerebrovasc Dis. 2014. PMID: 24739589 Review.
Cited by
-
Ameliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemic-reperfusion injury.Mol Med Rep. 2015 Jul;12(1):988-94. doi: 10.3892/mmr.2015.3515. Epub 2015 Mar 19. Mol Med Rep. 2015. PMID: 25815894 Free PMC article.
-
Current knowledge on the neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke.J Exp Pharmacol. 2015 Oct 1;7:17-28. doi: 10.2147/JEP.S63544. eCollection 2015. J Exp Pharmacol. 2015. PMID: 27186142 Free PMC article. Review.
-
Role of Citicoline in an in vitro AMD model.Aging (Albany NY). 2020 May 29;12(10):9031-9040. doi: 10.18632/aging.103164. Epub 2020 May 29. Aging (Albany NY). 2020. PMID: 32470946 Free PMC article.
-
Application of Citicoline in Neurological Disorders: A Systematic Review.Nutrients. 2020 Oct 12;12(10):3113. doi: 10.3390/nu12103113. Nutrients. 2020. PMID: 33053828 Free PMC article.
-
Efficacy of Neuroprotective Drugs in Acute Ischemic Stroke: Is It Helpful?J Neurosci Rural Pract. 2019 Oct;10(4):576-581. doi: 10.1055/s-0039-1700790. Epub 2019 Dec 11. J Neurosci Rural Pract. 2019. PMID: 31831974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical